Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,484,224
New position
Shares Held
183,473
first reported quarter
Ownership
0.070%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#105
of 625 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Derivatives in OGN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,805
PutShares
18,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $9,540,290 across 6 Drug Manufacturers - General names. OGN ranks #3 (26.0% of the industry book) .
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,484,224 | 183,473 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $2,805 | 18,700 | Put | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||